HNRNPA1P30

Across TCGA pan-cancer cohorts, HNRNPA1P30 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of HNRNPA1P30’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where HNRNPA1P30 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types HNRNPA1P30 is over-expressed in tumor, although a few such as UCEC show the opposite, repressed pattern.

HNSC, UCEC, and STAD are the cancer types where HNRNPA1P30 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HNRNPA1P30 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	IV	+0.084	.016	5	view →
UCEC	All	II,III,IV	−0.150	.027	4	view →
STAD	All	IV	+0.073	.005	2	view →
CHOL	All	All	+0.054	.013	2	view →
KIRC	All	All	+0.021	.022	2	view →
LUSC	All	All	+0.028	.035	1	view →
LIHC	All	II,III,IV	+0.020	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

HNRNPA1P30–HNSC

Open the HNSC breakdown →